Cargando…

The Potential of Combination Therapies and Patient Stratification to Improve CCR2 Inhibition Therapeutics

Detalles Bibliográficos
Autores principales:	Duex, Jason E., Theodorescu, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788950/ https://www.ncbi.nlm.nih.gov/pubmed/35083442 http://dx.doi.org/10.33696/immunology.3.099

Ejemplares similares

Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
por: Tu, Megan M., et al.
Publicado: (2020)

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling
por: Xiao, Jin-Fen, et al.
Publicado: (2021)

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer
por: Agarwal, Neeraj, et al.
Publicado: (2022)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis
por: Puengel, Tobias, et al.
Publicado: (2022)

The Vac14p–Fig4p complex acts independently of Vac7p and couples PI3,5P(2) synthesis and turnover
por: Duex, Jason E., et al.
Publicado: (2006)

CD44: A metastasis driver and therapeutic target
por: Sottnik, Joseph L., et al.
Publicado: (2016)

Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
por: Harris, Adrian L.
Publicado: (2019)

Stratification and therapeutic potential of PML in metastatic breast cancer
por: Martín-Martín, Natalia, et al.
Publicado: (2016)

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options
por: Hermsen, Mario A., et al.
Publicado: (2023)

CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
por: Gómez-Melero, Sara, et al.
Publicado: (2023)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
por: Shao, Zhehua, et al.
Publicado: (2022)

Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
por: Gilchrist, Annette, et al.
Publicado: (2022)

Norepinephrine Inhibits Macrophage Migration by Decreasing CCR2 Expression
por: Xiu, Fangming, et al.
Publicado: (2013)

An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
por: Yang, Yang, et al.
Publicado: (2021)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma
por: Dhaouadi, Tarak, et al.
Publicado: (2011)

Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
por: Riddy, Darren M, et al.
Publicado: (2021)

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study
por: Zhai, Tianyue, et al.
Publicado: (2023)

Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study
por: Kothandan, Gugan, et al.
Publicado: (2012)

CCR9 in cancer: oncogenic role and therapeutic targeting
por: Tu, Zhenbo, et al.
Publicado: (2016)

CCR4 as a Therapeutic Target for Cancer Immunotherapy
por: Yoshie, Osamu
Publicado: (2021)

The Role and Therapeutic Targeting of CCR5 in Breast Cancer
por: Hamid, Rasha, et al.
Publicado: (2023)

Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer
por: Ranasinghe, Ranmali, et al.
Publicado: (2018)

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2021)

Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
por: Pervaiz, Asim, et al.
Publicado: (2020)

CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
por: Grande, Fedora, et al.
Publicado: (2019)

Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4(+) Treg in nonhuman primates
por: Wang, Zhaohui, et al.
Publicado: (2018)

Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice
por: Guabiraba, Rodrigo, et al.
Publicado: (2010)

In silco analysis of carboxamide derivatives of piperidine as potential antagonists of CCR5
por: Harishchander, A, et al.
Publicado: (2014)

Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
por: Eltayeb, Sana, et al.
Publicado: (2007)

Two Distinct Regions in a Yeast Myosin-V Tail Domain Are Required for the Movement of Different Cargoes
por: Catlett, Natalie L., et al.
Publicado: (2000)

Correction: Norepinephrine Inhibits Macrophage Migration by Decreasing CCR2 Expression
por: Xiu, Fangming, et al.
Publicado: (2014)

CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow
por: Fujimura, Naoki, et al.
Publicado: (2015)

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
por: Xu, Maosen, et al.
Publicado: (2021)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

Improving Risk Stratification for Patients With Type 2 Myocardial Infarction
por: Taggart, Caelan, et al.
Publicado: (2023)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmnq1freavg5mk3ubvhojigcua